Intravitreal infliximab: Clinical Trials

2 trials of Intravitreal infliximab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow Intravitreal infliximab: new trials by email Literature Review of Intravitreal infliximab trials Research Report on Intravitreal infliximab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravitreal Infliximab for Proliferative Vitreoretinopathy
Intravitreal infliximab, Pars plana vitrectomy - Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy
Phase 2CompletedCairo University662021-11-262024-01-19
Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study
Intravitreal Infliximab - Behçet's Disease, Uveitis
Phase 1 / Phase 2CompletedCairo University202013-01-012015-12-03

Conditions studied

Behcet Syndrome (1)  ·  Retinal Detachment (1)  ·  Uveitis (1)  ·  Uveitis, Posterior (1)  ·  Vitreoretinopathy, Proliferative (1)

Sponsors

Cairo University (2)

Countries

Egypt (1)

Top investigators

Ahmed A Abdel-Kader, MD, PhD (1)  ·  Ahmed M Abdelbaki, MD, PhD (1)  ·  Ahmed M Younes, MD, MSc (1)  ·  Ayman G Elnahry, MD, PhD (1)  ·  Hany S Hamza, MD, PhD (1)  ·  Mahmoud Soliman, MD PhD (1)